Niklas Jonsson1, Tom Nilsen2, Patrik Gille-Johnson3, Max Bell4, Claes-Roland Martling4, Anders Larsson2, Johan Mårtensson4. 1. Section of Anaesthesia and Intensive Care Medicine, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. niklas.jonsson@karolinska.se. 2. Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden. 3. Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden. 4. Section of Anaesthesia and Intensive Care Medicine, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Abstract
BACKGROUND: Calprotectin is the most abundant protein in the cytosolic fraction of neutrophils, and neutrophil degranulation is a major response to bacterial infections. OBJECTIVES: To assess the value of plasma calprotectin as an early marker of bacterial infections in critically ill patients and compare it with the corresponding values for procalcitonin (PCT), C-reactive protein (CRP) and white blood cell count (WBC). METHODS: We measured daily plasma calprotectin levels in 110 intensive care unit patients using a newly developed turbidimetric assay run on clinical chemistry analysers. The likelihood of infection was determined according to the International Sepsis Forum criteria. RESULTS: Overall, 58 patients (52.7%) developed a suspected or confirmed bacterial infection. Plasma calprotectin predicted such infections within 24 hours with an area under the receiver operating characteristics curve (ROC area) of 0.78 (95% CI, 0.68-0.89). The ROC area for calprotectin was significantly greater than the corresponding ROC areas for WBC (P < 0.001) and PCT (P = 0.02) but only marginally better than the ROC area for CRP (0.71; 95% CI, 0.68-0.89). CONCLUSION: Plasma calprotectin appears to be a useful early marker of bacterial infections in critically ill patients, with better predictive characteristics than WBC and PCT.
BACKGROUND: Calprotectin is the most abundant protein in the cytosolic fraction of neutrophils, and neutrophil degranulation is a major response to bacterial infections. OBJECTIVES: To assess the value of plasma calprotectin as an early marker of bacterial infections in critically illpatients and compare it with the corresponding values for procalcitonin (PCT), C-reactive protein (CRP) and white blood cell count (WBC). METHODS: We measured daily plasma calprotectin levels in 110 intensive care unit patients using a newly developed turbidimetric assay run on clinical chemistry analysers. The likelihood of infection was determined according to the International Sepsis Forum criteria. RESULTS: Overall, 58 patients (52.7%) developed a suspected or confirmed bacterial infection. Plasma calprotectin predicted such infections within 24 hours with an area under the receiver operating characteristics curve (ROC area) of 0.78 (95% CI, 0.68-0.89). The ROC area for calprotectin was significantly greater than the corresponding ROC areas for WBC (P < 0.001) and PCT (P = 0.02) but only marginally better than the ROC area for CRP (0.71; 95% CI, 0.68-0.89). CONCLUSION: Plasma calprotectin appears to be a useful early marker of bacterial infections in critically illpatients, with better predictive characteristics than WBC and PCT.
Authors: Charalampos Pierrakos; Dimitrios Velissaris; Max Bisdorff; John C Marshall; Jean-Louis Vincent Journal: Crit Care Date: 2020-06-05 Impact factor: 9.097
Authors: James M Njunge; Agnes Gwela; Nelson K Kibinge; Moses Ngari; Lydia Nyamako; Emily Nyatichi; Johnstone Thitiri; Gerard Bryan Gonzales; Robert H J Bandsma; Judd L Walson; Evelyn N Gitau; James A Berkley Journal: Sci Rep Date: 2019-04-12 Impact factor: 4.379
Authors: Luis García de Guadiana-Romualdo; Carlos Rodríguez Rojas; Daniel Morell-García; David Andaluz-Ojeda; María Dolores Rodríguez Mulero; Enrique Rodríguez-Borja; Antonieta Ballesteros-Vizoso; María Dolores Calvo; Lourdes Albert-Botella; Adela Pozo Giráldez; Isabel Llompart-Alabern; Cristina Bolado Jiménez; Marta Hernández Olivo; Lucía Fernández Presa; Juan Ortega-Pérez; María José Fora Romero; Valerio Campos-Rodríguez; Andrea Ballester Férriz; Alexandra M Guiu-Martí; Leyre Pinilla Arribas; María Galindo Martínez; Edwin R Puerto-Lara; Ana Belen López Tarazaga; María Salomé Ros Braquehais; Leonor Nogales Martín; Celia Juez Santamaría; Wysalli Trapiello Fernández; Virginia Espinilla Fernández; Aleksandra Havelka; María Dolores Albaladejo-Otón Journal: Inflamm Res Date: 2021-10-30 Impact factor: 6.986
Authors: Michal Holub; Eva Bartáková; Alžběta Stráníková; Eva Koblihová; Simona Arientová; Marie Blahutová; Jan Máca; Miroslav Ryska Journal: Mediators Inflamm Date: 2019-09-09 Impact factor: 4.711